Promising results for APOC3 ASO in familial chylomicronemia syndrome
Promising results for APOC3 ASO in familial chylomicronemia syndrome
Increasing the use of SGLT2i and GLP-1RA with a remote program in T2D and high CV or kidney risk
Increasing the use of SGLT2i and GLP-1RA with a remote program in T2D and high CV or kidney risk
Self-assessment on statin eligibility without prescription using a web app
Self-assessment on statin eligibility without prescription using a web app
More than 70% lowering of triglycerides with APOC3 RNAi in patients with severe hypertriglyceridemia
More than 70% lowering of triglycerides with APOC3 RNAi in patients with severe hypertriglyceridemia
Semaglutide Reduces CV Events in Non-Diabetic, Overweight Patients
Semaglutide Reduces CV Events in Non-Diabetic, Overweight Patients
Stopping aspirin after 1 month DAPT in ACS patients after stenting
Stopping aspirin after 1 month DAPT in ACS patients after stenting
Head-to-head comparison of two TAVR devices in patients with aortic stenosis and small aortic annuli
Head-to-head comparison of two TAVR devices in patients with aortic stenosis and small aortic annuli
APOC3 ASO significantly lowers triglycerides in patients with hypertriglyceridemia and high CV risk
APOC3 ASO significantly lowers triglycerides in patients with hypertriglyceridemia and high CV risk
No improvements in CV outcomes at 90 days with human ApoA-1 infusions post-MI
No improvements in CV outcomes at 90 days with human ApoA-1 infusions post-MI
Early aggressive lipid-lowering strategy with PCSK9 siRNA performs better than usual care in US patients with ASCVD
Early aggressive lipid-lowering strategy with PCSK9 siRNA performs better than usual care in US patients with ASCVD
No effect on the primary endpoint with SGLT2i post-MI, but significant effect on HF hospitalizations
No effect on the primary endpoint with SGLT2i post-MI, but significant effect on HF hospitalizations
Beyond BeAT-HF: Integrating Barostim into a Comprehensive HF Program
Beyond BeAT-HF: Integrating Barostim into a Comprehensive HF Program
Allergic Reactions and Cardiac Concerns: Exploring the Heart Disease Link
Allergic Reactions and Cardiac Concerns: Exploring the Heart Disease Link
Active Aging: Preventing Heart Failure in Older Women with Exercise
Active Aging: Preventing Heart Failure in Older Women with Exercise
Improving CKD Patient Outcomes with SGLT2 Inhibitors
Improving CKD Patient Outcomes with SGLT2 Inhibitors
